Emmessar Biotech & Nutrition Ltd Price Today
Emmessar Biotech & Nutrition Ltd share price is
₹22.59 as on
09-Oct-2026,
Up 7.06%
from the previous close of ₹21.1.
The stock has traded between
₹22.77 and
₹22 today,
against a 52-week range of
₹18.42 to
₹33.39.
Over the past year the stock is
Down 81.27% range.
Market capitalisation stands at ₹11.45 crore.
Emmessar Biotech & Nutrition Limited (EBNL), originally established on 17th March 1992 as Emmessar Chemical Industries Ltd (ECIL) started its operations in manufacturing Super Specialty Fine Chemicals. The Company has so far, succeeded in developing many Specialty Fine Chemicals. ECIL gained official recognition for its R&D from DSIR, Ministry of Science & Technology, Government of India, New-Delhi in early 1996. To better represent its new core activity, a change in the Company name from Emmessar Chemical Industries Ltd (ECIL) to Emmessar Biotech & Nutrition Ltd (EBNL) on April 7, 2000, was made essential.
On realizing that some of the specialty chemicals developed & exported to USA & Europe was being used in producing healthcare formulations, the Company plunged into a new venture in the Healthcare business, where phenomenal growth in the coming decades was anticipated.
ECIL's research team established that the specialty chemicals made by them had potential as 'Vital Micro Nutrients', used worldwide in research as 'tools' of Biotechnology. The Company's management took opportunity to also enter the field of Biotechnology & Healthcare, at a time when across the world, healthcare ranked high in priority in both manufacturer's and consumer's minds.
EBNL's R&D pursued its research and while identifying potential markets for their products in Healthcare, the Company in 1998, entered into collaborative partnership with California based, Vibrant Life, a company well estab ...lished and reputed in the USA.
In FY 2025, EBNL's range of products have covered different aspects and unmet needs of Healthcare, which cater to and address obstinate skin problems, muscle problems, bone problems and other debilitating chronic physical ailments. Apart from this, the intellectual exchange of concepts and technology between Company, and Vibrant Life, led to path-breaking discoveries (VedaCeuticals) through a combination of core fundamentals of Nutraceuticals, Cosmeceuticals, Ayurveda, Biotechnology and Nanotechnology - giving them a new dimension to future products emerging from the stable.
1. Can I buy Emmessar Biotech & Nutrition Ltd from PL Capital? ›
Yes, you can invest in Emmessar Biotech & Nutrition Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Emmessar Biotech & Nutrition Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Emmessar Biotech & Nutrition Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.
2. Does Emmessar Biotech & Nutrition Ltd pay dividends? ›
Emmessar Biotech & Nutrition Ltd does not currently pay dividends. Investors in this case primarily benefit from capital appreciation, where the value of the stock may rise over time depending on business growth and market conditions.
3. What is the current share price of Emmessar Biotech & Nutrition Ltd ? ›
As of
09-Oct-2026 , 16:01:22 the share price for Emmessar Biotech & Nutrition Ltd. is ₹ 22.59 on the NSE (Note: Prices are dynamic and update frequently during market hours).
4. What is the 52-week high and low of Emmessar Biotech & Nutrition Ltd ? ›
The 52-week high and low of Emmessar Biotech & Nutrition Ltd share price is ₹ 18.42 - ₹ 33.39 as of
09-Oct-2026 , 16:01:22 .
5. What is the market capitalisation of Emmessar Biotech & Nutrition Ltd? ›
Market capitalisation of Emmessar Biotech & Nutrition Ltd is ₹11.45Cr as of 09-Oct-2026.
6. What is the current P/E ratio of Emmessar Biotech & Nutrition Ltd? ›
The P/E (price-to-earnings) ratio of Emmessar Biotech & Nutrition Ltd is 28.590.
7. What is the current P/B ratio of Emmessar Biotech & Nutrition Ltd? ›
The P/B (price-to-book) ratio of Emmessar Biotech & Nutrition Ltd is 1.390.
8. What is the shareholding pattern of Emmessar Biotech & Nutrition Ltd? ›
As of 09-Oct-2026, promoters hold 59.529%, foreign institutional investors hold 0.000%, domestic institutional investors hold 0.144%, and the public holds 38.067%.
9. What is the 1-year return of Emmessar Biotech & Nutrition Ltd? ›
The 1-year return of Emmessar Biotech & Nutrition Ltd is - 81.27%.
Open Your Demat Account with PL Capital now
10 Lakh+ Active users
Award Winning research insights
No hidden charges
Start Stock SIP
Start SIP in Emmessar Biotech & Nutrition Ltd
Invest systematically in stocks with the PL Capital app
